Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 2Sarcoma 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Myelodysplastic Syndromes 19Lymphoma, Non-Hodgkin 11Hodgkin Disease 10Leukemia, Biphenotypic, Acute 8Multiple Myeloma 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia 7Burkitt Lymphoma 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Myeloproliferative Disorders 6Neuroblastoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Anemia, Refractory, with Excess of Blasts 5Recurrence 4Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hematologic Neoplasms 4Breast Neoplasms 4Lymphoma, T-Cell 3Lymphoma, Follicular 3Leukemia, Myelomonocytic, Chronic 3Sarcoma 2Rhabdomyosarcoma 2Primary Myelofibrosis 2Neoplasms, Plasma Cell 2Myelodysplastic-Myeloproliferative Diseases 2Medulloblastoma 2

Interventions

Cyclophosphamide 12Biopsy 10Specimen Handling 9Whole-Body Irradiation 7Magnetic Resonance Spectroscopy 7pembrolizumab 6Peripheral Blood Stem Cell Transplantation 6Melphalan 6Etoposide 6fludarabine 5duvelisib 5Brentuximab Vedotin 5ruxolitinib 4fludarabine phosphate 4Vincristine 4Prednisone 4Doxorubicin 4Cytarabine 410-propargyl-10-deazaaminopterin 4romidepsin 3X-Rays 3Mycophenolic Acid 3Immunoglobulin G 3Granulocyte Colony-Stimulating Factor 3Gemcitabine 3Disulfides 3Carmustine 3venetoclax 2tazemetostat 2sodium-iodide symporter 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Lymphoma, T-Cell × Granulocyte Colony-Stimulating Factor × 1 year × Clear all
NCT07278856 2026-06-05

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

City of Hope Medical Center

Phase 1 Recruiting
20 enrolled
Lymphoid

Lymphoma, T-Cell

NCT03674411 2026-01-06

Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy

Masonic Cancer Center, University of Minnesota

Phase 2 Active not recruiting
22 enrolled 19 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmSarcoma

Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT03125642 2025-11-04

Auto Stem Cell Transplant for Lymphoma Patients

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
150 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡